BerandaCRL • BMV
add
Charles River Lbrtrs ntrntl Inc
Tutup sebelumnya
$2.953,57
Rentang tahun
$2.019,70 - $4.609,00
Kapitalisasi pasar
7,72Â M USD
Volume Rata-Rata
21,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NYSE
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 984,17Â jt | -2,71% |
Biaya operasional | 206,08Â jt | -1,77% |
Laba bersih | 25,47Â jt | -62,17% |
Margin laba bersih | 2,59 | -61,11% |
Penghasilan per saham | 2,34 | 3,08% |
EBITDA | 218,88Â jt | -4,14% |
Tarif pajak efektif | 28,07% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 229,36Â jt | -29,87% |
Total aset | 7,58Â M | -7,00% |
Total liabilitas | 4,34Â M | -2,43% |
Total ekuitas | 3,24 M | — |
Saham yang beredar | 49,12 jt | — |
Harga terhadap nilai buku | 45,41 | — |
Tingkat pengembalian aset | 4,43% | — |
Tingkat pengembalian modal | 5,35% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 25,47Â jt | -62,17% |
Kas dari operasi | 171,70Â jt | 32,19% |
Kas dari investasi | -45,48Â jt | 46,99% |
Kas dari pembiayaan | -105,32Â jt | -674,10% |
Perubahan kas bersih | 26,16Â jt | -51,61% |
Arus kas bebas | 147,04Â jt | 279,41% |
Tentang
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in preclinical and clinical laboratory, gene therapy and cell therapy services and supplies for the pharmaceutical, medical device and biotechnology industries.
The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories frequently criticized by animal rights activists, who condemn the company's use of dogs and primates for pharmaceutical research. The company is also a major harvester of blood from horseshoe crabs. Wikipedia
Didirikan
1947
Kantor pusat
Situs
Karyawan
19.400
